Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hyperaldosteronism | 70 | 2024 | 239 | 16.920 |
Why?
|
Adrenalectomy | 42 | 2024 | 342 | 5.770 |
Why?
|
Aldosterone | 41 | 2024 | 876 | 4.590 |
Why?
|
Adrenocortical Adenoma | 12 | 2023 | 48 | 3.870 |
Why?
|
Adrenal Cortex Neoplasms | 7 | 2021 | 162 | 2.070 |
Why?
|
Hypertension | 29 | 2023 | 8455 | 2.000 |
Why?
|
Adrenal Glands | 15 | 2023 | 547 | 1.870 |
Why?
|
Acute Kidney Injury | 13 | 2024 | 1967 | 1.380 |
Why?
|
G Protein-Coupled Inwardly-Rectifying Potassium Channels | 8 | 2023 | 64 | 1.120 |
Why?
|
Adrenal Gland Neoplasms | 6 | 2023 | 740 | 1.110 |
Why?
|
Adenoma | 9 | 2023 | 2168 | 1.050 |
Why?
|
Taiwan | 21 | 2023 | 496 | 1.040 |
Why?
|
Hydrocortisone | 10 | 2023 | 1825 | 1.000 |
Why?
|
Yttrium Radioisotopes | 2 | 2021 | 93 | 0.890 |
Why?
|
Interleukin-18 | 1 | 2022 | 248 | 0.780 |
Why?
|
Cushing Syndrome | 1 | 2020 | 249 | 0.660 |
Why?
|
Otoscopy | 1 | 2018 | 36 | 0.630 |
Why?
|
Renin | 9 | 2023 | 642 | 0.620 |
Why?
|
Diastole | 3 | 2020 | 791 | 0.610 |
Why?
|
Renal Dialysis | 7 | 2020 | 1780 | 0.610 |
Why?
|
Embolization, Therapeutic | 3 | 2021 | 1392 | 0.560 |
Why?
|
Renal Insufficiency, Chronic | 4 | 2024 | 2195 | 0.560 |
Why?
|
Ear Diseases | 1 | 2018 | 169 | 0.550 |
Why?
|
Creatinine | 6 | 2023 | 1916 | 0.530 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 2014 | 72 | 0.500 |
Why?
|
Salvage Therapy | 1 | 2021 | 1269 | 0.480 |
Why?
|
Ventricular Dysfunction, Left | 4 | 2020 | 2059 | 0.460 |
Why?
|
Hemofiltration | 1 | 2013 | 57 | 0.440 |
Why?
|
Liver Transplantation | 1 | 2023 | 2117 | 0.430 |
Why?
|
Uremia | 1 | 2013 | 200 | 0.420 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2016 | 964 | 0.400 |
Why?
|
Intracranial Pressure | 1 | 2013 | 326 | 0.380 |
Why?
|
Otolaryngology | 1 | 2018 | 644 | 0.380 |
Why?
|
Liver Neoplasms | 3 | 2021 | 4249 | 0.370 |
Why?
|
Glomerular Filtration Rate | 6 | 2024 | 2167 | 0.370 |
Why?
|
Drug Delivery Systems | 1 | 2021 | 2217 | 0.360 |
Why?
|
Humans | 100 | 2024 | 742088 | 0.350 |
Why?
|
Education, Medical, Undergraduate | 1 | 2018 | 1004 | 0.330 |
Why?
|
Renal Replacement Therapy | 3 | 2021 | 258 | 0.320 |
Why?
|
Cardiovascular Diseases | 3 | 2022 | 15108 | 0.310 |
Why?
|
Middle Aged | 48 | 2023 | 213127 | 0.300 |
Why?
|
Kidney Failure, Chronic | 6 | 2020 | 2536 | 0.280 |
Why?
|
Mitral Valve | 1 | 2014 | 1484 | 0.270 |
Why?
|
Adult | 39 | 2023 | 213712 | 0.270 |
Why?
|
Ventricular Remodeling | 4 | 2023 | 1224 | 0.260 |
Why?
|
Steroid 11-beta-Hydroxylase | 2 | 2022 | 20 | 0.260 |
Why?
|
Ventricular Function, Left | 2 | 2016 | 3656 | 0.260 |
Why?
|
Treatment Outcome | 23 | 2023 | 62966 | 0.260 |
Why?
|
Male | 51 | 2023 | 349538 | 0.260 |
Why?
|
Female | 49 | 2023 | 379592 | 0.240 |
Why?
|
Retrospective Studies | 30 | 2023 | 77098 | 0.240 |
Why?
|
Captopril | 2 | 2023 | 272 | 0.220 |
Why?
|
Hypertrophy, Left Ventricular | 4 | 2023 | 859 | 0.220 |
Why?
|
Hemodynamics | 1 | 2013 | 4197 | 0.220 |
Why?
|
Tissue Inhibitor of Metalloproteinase-2 | 1 | 2022 | 68 | 0.220 |
Why?
|
Adosterol | 2 | 2023 | 6 | 0.220 |
Why?
|
Calcium Channels, T-Type | 1 | 2022 | 34 | 0.210 |
Why?
|
Clinical Competence | 1 | 2018 | 4681 | 0.210 |
Why?
|
Aged | 32 | 2023 | 162944 | 0.200 |
Why?
|
Cerebral Hemorrhage | 1 | 2013 | 2643 | 0.200 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2014 | 3328 | 0.200 |
Why?
|
Prospective Studies | 13 | 2024 | 53187 | 0.200 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2022 | 11695 | 0.200 |
Why?
|
Renal Insufficiency | 2 | 2022 | 802 | 0.200 |
Why?
|
Antihypertensive Agents | 5 | 2023 | 2043 | 0.190 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6754 | 0.190 |
Why?
|
Imaging, Three-Dimensional | 1 | 2014 | 4029 | 0.190 |
Why?
|
Echocardiography | 6 | 2023 | 5097 | 0.190 |
Why?
|
Spironolactone | 2 | 2021 | 382 | 0.190 |
Why?
|
Adrenal Cortex Function Tests | 1 | 2019 | 13 | 0.180 |
Why?
|
Radiation Pneumonitis | 1 | 2020 | 104 | 0.180 |
Why?
|
Blood Specimen Collection | 3 | 2021 | 246 | 0.180 |
Why?
|
Mitochondria, Heart | 1 | 2021 | 247 | 0.180 |
Why?
|
Radiopharmaceuticals | 2 | 2020 | 2658 | 0.180 |
Why?
|
Hearing Aids | 1 | 2020 | 56 | 0.180 |
Why?
|
Cohort Studies | 7 | 2024 | 40450 | 0.170 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2023 | 1239 | 0.170 |
Why?
|
Pericardium | 1 | 2023 | 667 | 0.170 |
Why?
|
Brachial Artery | 1 | 2020 | 370 | 0.170 |
Why?
|
Obesity, Abdominal | 1 | 2021 | 361 | 0.160 |
Why?
|
Specimen Handling | 2 | 2020 | 692 | 0.160 |
Why?
|
Aftercare | 1 | 2024 | 860 | 0.150 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2020 | 2211 | 0.150 |
Why?
|
Echocardiography, Transesophageal | 1 | 2023 | 1129 | 0.150 |
Why?
|
Patient Positioning | 1 | 2019 | 322 | 0.140 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1792 | 0.140 |
Why?
|
GPI-Linked Proteins | 1 | 2018 | 434 | 0.140 |
Why?
|
Risk Factors | 13 | 2024 | 72145 | 0.140 |
Why?
|
DNA, Mitochondrial | 1 | 2021 | 814 | 0.140 |
Why?
|
Health Status Indicators | 2 | 2012 | 968 | 0.140 |
Why?
|
Prevalence | 6 | 2023 | 15194 | 0.140 |
Why?
|
Leukocytes, Mononuclear | 1 | 2022 | 1835 | 0.130 |
Why?
|
Consensus | 3 | 2021 | 2935 | 0.130 |
Why?
|
Angiography | 1 | 2020 | 1636 | 0.130 |
Why?
|
Cardiomegaly | 1 | 2018 | 619 | 0.130 |
Why?
|
Metabolic Diseases | 1 | 2021 | 657 | 0.130 |
Why?
|
Proton Pump Inhibitors | 1 | 2020 | 521 | 0.130 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2018 | 292 | 0.120 |
Why?
|
Bundle-Branch Block | 1 | 2016 | 270 | 0.120 |
Why?
|
Prognosis | 9 | 2021 | 29010 | 0.120 |
Why?
|
Venous Thrombosis | 1 | 2023 | 1237 | 0.120 |
Why?
|
Heart Failure | 3 | 2023 | 10856 | 0.120 |
Why?
|
Mutation | 7 | 2023 | 29717 | 0.120 |
Why?
|
Radionuclide Imaging | 1 | 2017 | 2027 | 0.110 |
Why?
|
Hearing Loss | 1 | 2020 | 765 | 0.110 |
Why?
|
Stroke Volume | 2 | 2016 | 4983 | 0.110 |
Why?
|
Diabetes Mellitus | 2 | 2023 | 5724 | 0.100 |
Why?
|
Hospitals | 2 | 2023 | 3937 | 0.100 |
Why?
|
Automation | 1 | 2014 | 584 | 0.100 |
Why?
|
Observer Variation | 2 | 2016 | 2593 | 0.100 |
Why?
|
Diabetic Nephropathies | 1 | 2018 | 983 | 0.100 |
Why?
|
Atrial Fibrillation | 2 | 2020 | 5019 | 0.100 |
Why?
|
Sepsis | 2 | 2018 | 2589 | 0.100 |
Why?
|
Ankle Brachial Index | 2 | 2022 | 154 | 0.100 |
Why?
|
Venous Thromboembolism | 1 | 2023 | 1668 | 0.090 |
Why?
|
Educational Measurement | 1 | 2018 | 1206 | 0.090 |
Why?
|
Myocardial Contraction | 1 | 2016 | 1585 | 0.090 |
Why?
|
Kidney Function Tests | 3 | 2022 | 683 | 0.090 |
Why?
|
Alleles | 1 | 2021 | 6931 | 0.090 |
Why?
|
Mortality | 1 | 2021 | 2857 | 0.090 |
Why?
|
Kaplan-Meier Estimate | 1 | 2021 | 6534 | 0.090 |
Why?
|
Disease Management | 2 | 2021 | 2450 | 0.090 |
Why?
|
Predictive Value of Tests | 5 | 2020 | 15056 | 0.090 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 9941 | 0.090 |
Why?
|
Receptors, Mineralocorticoid | 2 | 2021 | 164 | 0.080 |
Why?
|
Time Factors | 7 | 2021 | 40054 | 0.080 |
Why?
|
Incidence | 7 | 2020 | 20928 | 0.080 |
Why?
|
Comorbidity | 6 | 2020 | 10372 | 0.080 |
Why?
|
Interleukin-6 | 1 | 2018 | 3199 | 0.080 |
Why?
|
Autoimmune Diseases | 1 | 2020 | 2130 | 0.080 |
Why?
|
Aged, 80 and over | 11 | 2020 | 57683 | 0.080 |
Why?
|
Statistics, Nonparametric | 3 | 2019 | 2885 | 0.080 |
Why?
|
Cross-Over Studies | 1 | 2013 | 2030 | 0.080 |
Why?
|
Intensive Care Units | 3 | 2016 | 3679 | 0.080 |
Why?
|
Liver | 1 | 2023 | 7470 | 0.080 |
Why?
|
Fibroblasts | 1 | 2018 | 4143 | 0.070 |
Why?
|
RNA, Messenger | 1 | 2022 | 13029 | 0.070 |
Why?
|
Risk Assessment | 8 | 2021 | 23320 | 0.070 |
Why?
|
Critical Illness | 3 | 2021 | 2665 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2020 | 3861 | 0.070 |
Why?
|
Reproducibility of Results | 4 | 2023 | 19862 | 0.070 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2019 | 1808 | 0.070 |
Why?
|
Tomography, X-Ray Computed | 3 | 2021 | 20086 | 0.070 |
Why?
|
Follow-Up Studies | 7 | 2022 | 39004 | 0.070 |
Why?
|
Blood Glucose | 1 | 2020 | 6249 | 0.070 |
Why?
|
Community-Acquired Infections | 1 | 2010 | 463 | 0.070 |
Why?
|
Antitubercular Agents | 1 | 2014 | 1319 | 0.070 |
Why?
|
Hospital Mortality | 6 | 2018 | 5310 | 0.070 |
Why?
|
Internet | 1 | 2018 | 3062 | 0.070 |
Why?
|
Societies, Medical | 1 | 2017 | 3740 | 0.060 |
Why?
|
Body Mass Index | 1 | 2023 | 12695 | 0.060 |
Why?
|
Myocardium | 1 | 2018 | 4775 | 0.060 |
Why?
|
Pilot Projects | 2 | 2019 | 8297 | 0.060 |
Why?
|
Databases, Factual | 4 | 2020 | 7716 | 0.060 |
Why?
|
Biological Assay | 2 | 2018 | 652 | 0.060 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2018 | 3038 | 0.060 |
Why?
|
Abdomen | 1 | 2009 | 1107 | 0.060 |
Why?
|
Fibrosis | 2 | 2022 | 2026 | 0.060 |
Why?
|
Veins | 2 | 2018 | 769 | 0.060 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2010 | 687 | 0.060 |
Why?
|
Bacteremia | 1 | 2010 | 962 | 0.060 |
Why?
|
Cardiac Surgical Procedures | 1 | 2018 | 3526 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2018 | 10472 | 0.050 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8425 | 0.050 |
Why?
|
MicroRNAs | 1 | 2018 | 3731 | 0.050 |
Why?
|
Propensity Score | 2 | 2019 | 1771 | 0.050 |
Why?
|
Laparoscopy | 1 | 2014 | 2121 | 0.050 |
Why?
|
Lung | 1 | 2020 | 9826 | 0.050 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2023 | 648 | 0.050 |
Why?
|
Technetium Tc 99m Aggregated Albumin | 1 | 2020 | 66 | 0.050 |
Why?
|
Tuberculosis | 1 | 2014 | 1904 | 0.050 |
Why?
|
Cytochromes c | 1 | 2021 | 180 | 0.050 |
Why?
|
Kidney Diseases | 1 | 2012 | 2145 | 0.050 |
Why?
|
Case-Control Studies | 4 | 2019 | 21719 | 0.050 |
Why?
|
Staphylococcal Infections | 1 | 2010 | 1398 | 0.050 |
Why?
|
Liver Circulation | 1 | 2020 | 163 | 0.050 |
Why?
|
Cosyntropin | 1 | 2020 | 33 | 0.050 |
Why?
|
Obesity | 1 | 2023 | 12705 | 0.050 |
Why?
|
Feasibility Studies | 2 | 2021 | 5062 | 0.050 |
Why?
|
Catheters | 1 | 2023 | 422 | 0.050 |
Why?
|
Cystatin C | 1 | 2021 | 250 | 0.050 |
Why?
|
Calcium Channel Blockers | 1 | 2023 | 689 | 0.040 |
Why?
|
Hyperplasia | 1 | 2023 | 1183 | 0.040 |
Why?
|
Chromatography, Liquid | 1 | 2023 | 977 | 0.040 |
Why?
|
Catheterization | 2 | 2017 | 1468 | 0.040 |
Why?
|
Diuretics | 1 | 2022 | 591 | 0.040 |
Why?
|
Cross-Sectional Studies | 4 | 2022 | 24913 | 0.040 |
Why?
|
Retreatment | 1 | 2020 | 604 | 0.040 |
Why?
|
Caspase 3 | 1 | 2021 | 759 | 0.040 |
Why?
|
Critical Care | 1 | 2011 | 2640 | 0.040 |
Why?
|
Cytokine Receptor gp130 | 1 | 2018 | 66 | 0.040 |
Why?
|
Thrombectomy | 1 | 2023 | 679 | 0.040 |
Why?
|
Steroids | 1 | 2023 | 931 | 0.040 |
Why?
|
Pulmonary Circulation | 1 | 2020 | 739 | 0.040 |
Why?
|
ROC Curve | 2 | 2018 | 3528 | 0.040 |
Why?
|
Survival Analysis | 3 | 2018 | 10248 | 0.040 |
Why?
|
Germany | 1 | 2019 | 860 | 0.040 |
Why?
|
Proportional Hazards Models | 3 | 2018 | 12344 | 0.040 |
Why?
|
Angiotensin Receptor Antagonists | 1 | 2023 | 923 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2019 | 15530 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 21821 | 0.040 |
Why?
|
Phlebotomy | 1 | 2018 | 142 | 0.040 |
Why?
|
Tandem Mass Spectrometry | 1 | 2023 | 1157 | 0.040 |
Why?
|
Stroke | 1 | 2019 | 9963 | 0.040 |
Why?
|
Kidney | 2 | 2022 | 7167 | 0.040 |
Why?
|
Microspheres | 1 | 2019 | 777 | 0.030 |
Why?
|
Phlebography | 1 | 2017 | 333 | 0.030 |
Why?
|
Hormones | 1 | 2020 | 884 | 0.030 |
Why?
|
Blood Pressure Determination | 1 | 2019 | 632 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2021 | 3133 | 0.030 |
Why?
|
Echocardiography, Doppler | 1 | 2019 | 934 | 0.030 |
Why?
|
Ontario | 1 | 2016 | 381 | 0.030 |
Why?
|
Siblings | 1 | 2019 | 854 | 0.030 |
Why?
|
Area Under Curve | 1 | 2019 | 1653 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2021 | 2024 | 0.030 |
Why?
|
Infusions, Intravenous | 1 | 2019 | 2271 | 0.030 |
Why?
|
Canada | 1 | 2020 | 2061 | 0.030 |
Why?
|
Fasting | 1 | 2020 | 1589 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1780 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 21596 | 0.030 |
Why?
|
Blood Pressure | 2 | 2023 | 8541 | 0.030 |
Why?
|
Thrombolytic Therapy | 1 | 2023 | 2161 | 0.030 |
Why?
|
Internationality | 1 | 2019 | 1002 | 0.030 |
Why?
|
Remission Induction | 1 | 2019 | 2384 | 0.030 |
Why?
|
Reactive Oxygen Species | 1 | 2021 | 2077 | 0.030 |
Why?
|
Surgery, Computer-Assisted | 1 | 2021 | 1009 | 0.030 |
Why?
|
Sex Distribution | 1 | 2018 | 2295 | 0.030 |
Why?
|
Polysomnography | 1 | 2019 | 1772 | 0.030 |
Why?
|
DNA Mutational Analysis | 1 | 2021 | 4187 | 0.030 |
Why?
|
Myocytes, Cardiac | 1 | 2021 | 1636 | 0.030 |
Why?
|
Age Distribution | 1 | 2018 | 2900 | 0.030 |
Why?
|
Radiation Dosage | 1 | 2020 | 1927 | 0.030 |
Why?
|
APACHE | 1 | 2012 | 277 | 0.030 |
Why?
|
Anti-Bacterial Agents | 1 | 2010 | 7153 | 0.030 |
Why?
|
Age of Onset | 1 | 2018 | 3266 | 0.020 |
Why?
|
Diagnosis, Differential | 2 | 2020 | 12958 | 0.020 |
Why?
|
Reference Values | 1 | 2018 | 4982 | 0.020 |
Why?
|
Regression Analysis | 1 | 2020 | 6452 | 0.020 |
Why?
|
Young Adult | 4 | 2020 | 56350 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2018 | 6313 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3557 | 0.020 |
Why?
|
Adiposity | 1 | 2020 | 1806 | 0.020 |
Why?
|
Potassium | 1 | 2014 | 1336 | 0.020 |
Why?
|
Postoperative Complications | 1 | 2012 | 15244 | 0.020 |
Why?
|
Collagen | 1 | 2018 | 2684 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2021 | 13814 | 0.020 |
Why?
|
Population Surveillance | 1 | 2020 | 2616 | 0.020 |
Why?
|
Disease Progression | 2 | 2018 | 13256 | 0.020 |
Why?
|
Linear Models | 1 | 2019 | 5948 | 0.020 |
Why?
|
Vascular Surgical Procedures | 1 | 2018 | 1473 | 0.020 |
Why?
|
Neutrophils | 1 | 2021 | 3711 | 0.020 |
Why?
|
Point-of-Care Systems | 1 | 2017 | 1175 | 0.020 |
Why?
|
Anticoagulants | 1 | 2023 | 4595 | 0.020 |
Why?
|
Cause of Death | 1 | 2018 | 3571 | 0.020 |
Why?
|
Observation | 1 | 2009 | 312 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11363 | 0.020 |
Why?
|
Mass Screening | 1 | 2023 | 5238 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 15994 | 0.020 |
Why?
|
Patient Selection | 1 | 2019 | 4214 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9846 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2020 | 7770 | 0.020 |
Why?
|
Insulin | 1 | 2020 | 6575 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10392 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3510 | 0.020 |
Why?
|
Mice, Transgenic | 1 | 2018 | 9735 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2009 | 1184 | 0.020 |
Why?
|
Multivariate Analysis | 1 | 2018 | 12242 | 0.010 |
Why?
|
Registries | 1 | 2019 | 8077 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2020 | 13921 | 0.010 |
Why?
|
Animals | 3 | 2021 | 168561 | 0.010 |
Why?
|
Mice | 2 | 2021 | 81045 | 0.010 |
Why?
|
Contrast Media | 1 | 2016 | 5295 | 0.010 |
Why?
|
Electrocardiography | 1 | 2016 | 6440 | 0.010 |
Why?
|
Age Factors | 1 | 2019 | 18355 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9715 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2018 | 19223 | 0.010 |
Why?
|
Survivors | 1 | 2012 | 2286 | 0.010 |
Why?
|
Models, Biological | 1 | 2018 | 9581 | 0.010 |
Why?
|
Adolescent | 2 | 2022 | 85649 | 0.010 |
Why?
|
Logistic Models | 1 | 2012 | 13403 | 0.010 |
Why?
|
Signal Transduction | 1 | 2018 | 23387 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 35342 | 0.010 |
Why?
|